6.905
Cartesian Therapeutics Inc 주식(RNAC)의 최신 뉴스
What MACD trends signal for Cartesian Therapeutics Inc. (1S70) stockPortfolio Return Summary & Reliable Volume Spike Alerts - Newser
Why Cartesian Therapeutics Inc. (1S70) stock stays undervaluedJuly 2025 Price Swings & Verified Momentum Stock Alerts - Newser
Weekly Earnings: What is the fair value estimate for Cartesian Therapeutics Inc 1S70 stock in 20252025 AllTime Highs & Reliable Volume Spike Trade Alerts - BỘ NỘI VỤ
What is the fair value estimate for Cartesian Therapeutics Inc. (1S70) stock in 2025Bond Market & Verified Momentum Stock Watchlist - Newser
Is Cartesian Therapeutics Inc. (1S70) stock a buy for dividend portfoliosEarnings Trend Report & Weekly Stock Breakout Alerts - Newser
Is Cartesian Therapeutics Inc. stock cheap at current valuationEarnings Growth Report & Real-Time Volume Analysis - Newser
Will Cartesian Therapeutics Inc. (1S70) stock outperform global peers2025 Big Picture & Technical Entry and Exit Alerts - Newser
What makes Cartesian Therapeutics Inc. (1S70) stock appealing to growth investorsQuarterly Profit Review & High Accuracy Buy Signal Tips - Newser
Why Cartesian Therapeutics Inc. (1S70) stock remains stableEarnings Risk Report & Community Driven Trade Alerts - Newser
Cartesian Therapeutics, Inc. (RNAC) 7.5% in After-hours: Amid Routine Trading Conditions - Stocks Telegraph
Is Cartesian Therapeutics Inc. stock in correction or buying zoneJuly 2025 Update & Accurate Intraday Trade Tips - moha.gov.vn
Free cash flow per share of Cartesian Therapeutics, Inc. – MUN:1S70 - TradingView
Book value per share of Cartesian Therapeutics, Inc. – MUN:1S70 - TradingView
Is Umiya Tubes Limited Stock Risky in the Current Market EnvironmentInsider Selling Patterns & High Return Capital Gains - earlytimes.in
Will Cartesian Therapeutics Inc. stock deliver better than expected guidance - BỘ NỘI VỤ
Automated Systems Holdings Limited Announces Change in Share Registrar - The Globe and Mail
Brokerages Set Cartesian Therapeutics, Inc. (NASDAQ:RNAC) Target Price at $38.00 - Defense World
Will Cartesian Therapeutics Inc. (1S70) stock outperform energy sector in 2025July 2025 Levels & Weekly High Conviction Ideas - newser.com
Will Cartesian Therapeutics Inc. (1S70) stock attract long term capital inflowsBear Alert & Daily Price Action Insights - newser.com
Is Cartesian Therapeutics Inc. stock a defensive play in 2025July 2025 Snapshot & Target Return Focused Picks - newser.com
How Cartesian Therapeutics Inc. (1S70) stock trades in high volatilityTrade Analysis Report & Risk Managed Trade Strategies - newser.com
Will Cartesian Therapeutics Inc. (1S70) stock recover faster than industryWeekly Stock Analysis & Low Risk Growth Stock Ideas - newser.com
HC Wainwright Has Lowered Expectations for Cartesian Therapeutics (NASDAQ:RNAC) Stock Price - Defense World
Is Cartesian Therapeutics Inc. a candidate for recovery playWeekly Profit Summary & Consistent Return Investment Signals - newser.com
[Form 4] Cartesian Therapeutics, Inc. Insider Trading Activity - Stock Titan
H.C. Wainwright lowers Cartesian Therapeutics stock price target to $30 from $40 By Investing.com - Investing.com South Africa
Dir Singer Gifts 20,000 Of Cartesian Therapeutics Inc [RNAC] - TradingView
Ranking Cartesian Therapeutics Inc. among high performing stocks via tools2025 Buyback Activity & Fast Gain Stock Trading Tips - newser.com
H.C. Wainwright lowers Cartesian Therapeutics stock price target to $30 from $40 - Investing.com Canada
What indicators show strength in Cartesian Therapeutics Inc.July 2025 Recap & AI Powered Buy and Sell Recommendations - newser.com
HC Wainwright & Co. Maintains Cartesian Therapeutics (RNAC) Buy Recommendation - Nasdaq
How Cartesian Therapeutics Inc. stock performs during Fed tightening cyclesQuarterly Portfolio Report & Entry and Exit Point Strategies - newser.com
HC Wainwright & Co. Lowers Price Target for RNAC Despite Maintai - GuruFocus
Cartesian Therapeutics (RNAC) Receives Lowered Price Target but Retains Buy Rating - GuruFocus
자본화:
|
볼륨(24시간):